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Systemic analysis for chromosomal instability and inactivation of cell cycle checkpoints are scarce during
hepatocarcinogenesis. We studied 24 patients with chronic B viral cirrhosis including 30 cirrhotic regenerative
nodules, 35 low-grade dysplastic nodules, 15 high-grade dysplastic nodules, 7 dysplastic nodules with
hepatocellular carcinoma foci, and 18 hepatocellular carcinomas. Eight normal livers were studied as the
control group. Telomere length and micronuclei were detected by Southern blot and Feulgen-fast green dyeing
technique, respectively, and p21WAF1/CIP1 expression was studied by immunohistochemistry. Micronuclei41 per
3000 hepatocytes were found in 17% of low-grade dysplastic nodules, 87% of high-grade dysplastic nodules,
and 100% of high-grade dysplastic nodules with hepatocellular carcinoma foci and hepatocellular carcinomas
in contrast to those of all normal livers, and 90% of cirrhosis showed no micronuclei. The micronuclei index
showed a gradual increase during hepatocarcinogenesis and there was a significant increase between cirrhosis
and low-grade dysplastic nodules, low-grade dysplastic nodules and high-grade dysplastic nodules, and high-
grade dysplastic nodules and hepatocellular carcinomas. Telomere length showed a gradual shortening during
hepatocarcinogenesis and a significant reduction was found in high-grade dysplastic nodules (P¼ 0.024) and
hepatocellular carcinomas (P¼ 0.031) compared with normal and cirrhotic livers. The micronuclei index was
correlated with telomere shortening (P¼ 0.016). The p21WAF1/CIP1 labeling index was significantly higher in
cirrhosis than in normal livers (P¼ 0.024) and markedly decreased in low-grade dysplastic nodules, high-grade
dysplastic nodules, and hepatocellular carcinomas compared with cirrhosis (Po0.05). The p21WAF1/CIP1 labeling
index was associated with telomere length (Po0.001) but not micronuclei index. This study shows that telomere
shortening, chromosomal instability, and inactivation of p21WAF1/CIP1 checkpoint function occur in low-grade
dysplastic nodules as well as in high-grade dysplastic nodules, and their cooperation is considered to be
critical for malignant transformation during hepatitis B virus associated-multistep hepatocarcinogenesis.
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Hepatocellular carcinoma is the fifth most common
cancer and the prognosis of patients with hepato-
cellular carcinoma is generally very poor, therefore,
the diagnosis and treatment of precancerous lesions
in the early stage of hepatocarcinogenesis is im-
portant.1 Dysplastic nodules, which usually occur in
cirrhotic livers, are nodular lesions that differ from
the surrounding parenchyma with regard to size,
color, and texture. Dysplastic nodules can be
classified as low or high grade according to the
degree of cytological and architectural atypia on
histological examination.2 High-grade dysplastic
nodules have been reported to have pathological
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characteristics similar to hepatocellular carcinomas,
but the nature of low-grade dysplastic nodules has
not been clearly described.3,4 Two recent follow-up
studies reported the natural history of large hepatic
nodules. Borzio et al followed 90 cirrhotic patients
with histologically proven large regenerative
nodules (n¼ 56), low-grade dysplastic nodules
(n¼ 16), and high-grade dysplastic nodules
(n¼ 19), and reported that the presence of high-
grade dysplastic nodules was associated with an
increased hazard risk for hepatocellular carcinoma
(2.4 over a mean follow-up period of 33 months).
However, low-grade dysplastic nodules were not at
increased risk for hepatocellular carcinoma devel-
opment.5 In another study, Kobayashi et al followed
154 patients with histologically proven large regen-
erative nodules (n¼ 99), low-grade dysplastic no-
dules (n¼ 42), and high-grade dysplastic nodules
(n¼ 23) for a median period of 2.8 years. The hazard
ratios for high-grade dysplastic nodule, low-grade
dysplastic nodule, and large regenerative nodule for
hepatocellular carcinoma development were 16.8,
2.96, and 1, respectively, and approximate annual
development rate to hepatocellular carcinoma
was 20% in patients with high-grade dysplastic
nodule and 10% in those with low-grade dysplastic
nodule.6
The telomere is a TTAGGG-repeat sequence
located at the end of the chromosome that is not
replicated during the S phase of the cell cycle, and is
shortened with each cell division of somatic cells.7
When telomeres shorten to a critical length, cells
lose their telomere-capping function and suffer
genetic changes because of chromosomal instability,
defined as an increased rate of chromosome aberra-
tions and aneuploidies, particularly involving
breakage/fusion/bridge cycles after telomere loss.8
Most hepatocellular carcinomas are characterized by
chromosomal instability with aneuploidy and
chromosomal aberrations, which is more common
in hepatitis B virus-associated hepatocellular
carcinomas.9–11 We earlier reported a gradual telo-
mere shortening in the progression of human
multistep hepatocarcinogenesis.12,13 A significant
telomere shortening occurred during the transition
from low-grade dysplastic nodules to high-grade
dysplastic nodules, and hepatocellular carcinomas
showed the shortest telomere length. It is interesting
to note that 14–17% of low-grade dysplastic nodules
showed a shortening of telomere length up to the
level of high-grade dysplastic nodules, and there
was no histological difference between low-grade
dysplastic nodules with or without telomere
shortening.12
The micronucleus, an indicator of chromosome
damage, arises from chromosome fragments or
whole chromosomes in the anaphase and telophase
stages and manifest as small nuclei in the
cytoplasm of interphase cells, and therefore are
regarded as indicators of genomic instability in
dividing cells.14–19 In rodent models of experimental
hepatocarcinogenesis, the number of micronuclei
increased with progression of hepatocarcinogenesis
as measured by genetic alterations.16,17 Micronu-
cleated hepatocytes have also been reported to be
significantly more frequent in hepatocellular
carcinomas compared with cirrhotic regenerative
nodules and normal hepatic parenchyma.19
However, little is known about micronuclei
formation in defined pathological lesions
including dysplastic nodules of human multistep
hepatocarcinogenesis.
The loss of telomere integrity induces a DNA
damage response involving the cell cycle check-
point pathways, which leads to permanent cell cycle
arrest at the senescence stage.7,20,21 Senescence is
regarded as a tumor suppressor mechanism that
prevents proliferation of genetically unstable pre-
cancerous cells. When cell cycle checkpoints are
inactivated, the carcinogenic process can be pro-
voked and has been reported in several human
cancers, including hepatocellular carcinoma.22–24
There have been increasing studies of the pre-
neoplasia-carcinoma sequence of hepatocellular
carcinoma at the molecular level. However, a
systemic assessment of telomere length, chromoso-
mal instability, and inactivation of cell cycle
checkpoints has not been investigated in defined
lesions of human multistep hepatocarcinogenesis.
We therefore studied telomere length, micronuclei,
and p21WAF1/CIP1 expression and their relationship in
cirrhotic livers, dysplastic nodules, and hepato-
cellular carcinomas of hepatitis B virus-associated
human multistep hepatocarcinogenesis.
Materials and methods
Tissue Samples and Pathological Examination
We studied hepatitis B virus-associated multistep
hepatocarcinogenesis in 24 patients. In total, 19 men
and 5 women were enrolled in this study, and their
ages ranged from 32 to 60 years (51±7.5 years,
mean±s.d.). They were all positive for serum
HBsAg and negative for anti-HCV. There were 30
cirrhotic nodules including six large regenerative
nodules, 35 low-grade dysplastic nodules, 15 high-
grade dysplastic nodules, 7 dysplastic nodules with
hepatocellular carcinoma foci, and 18 hepatocellu-
lar carcinomas. Fresh liver tissues, sampled from
resected or explanted liver specimens, were snap-
frozen in liquid nitrogen and stored at 701C until
use. Representative sections were submitted for
routine histological examination. Clinical and
pathological features of patients are summarized in
Table 1. All nodular lesions were evaluated accord-
ing to the criteria proposed by the International
Working Party on the terminology of nodular
hepatocellular lesions (Figure 1).2 Hepatocellular
carcinoma differentiation was determined on the
basis of the Edmondson and Steiner classification.25
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All of the non-hepatocellular carcinoma liver sam-
ples showed hepatitis B virus-associated cirrhosis.
For comparison with normal livers, non-neoplastic
liver samples were obtained from eight patients with
metastatic colorectal carcinomas. The controls did
not have the hepatitis virus and showed relatively
normal liver histology, with the exception of mild
steatosis. There were four men and two women, and
their ages ranged from 42 to 66 years (54±9.7 years,
mean±s.d.). This study was approved by the
Institutional Review Board of Severance Hospital,
Yonsei University College of Medicine, and liver
specimens were provided by the Liver Cancer
Specimen Bank of the National Research
Resource Bank Program of the Korea Science and
Engineering Foundation of the Ministry of Science
and Technology.
Micronuclei Study
Micronuclei of hepatocytes were identified by
Feulgen-fast green dyeing technique. Formalin-fixed
paraffin-embedded tissue sections (4 mm) were de-
paraffinized with xylene for 30 min, rehydrated with
graded alcohol, and then immersed in 0.1 M hydro-
chloric acid at 601C for 5 min. Slides were then
immersed in Schiff reagent for 30 min until the
nuclei were stained, and were then transferred
directly to bisulfate water, followed by rinsing under
running tap water. Counterstaining was carried out
with 0.1% fast green for 30 s.
The presence of micronuclei was defined using
the following criteria: (1) a diameter smaller than
one-third of the nucleus, (2) non-refractive to be
distinguished from artifacts such as small staining
particles, (3) no connection to the main nucleus, and
(4) the same staining intensity as the main nucleus,
although staining may occasionally be more in-
tense.19 Hepatocytes with pyknotic nuclei and those
that overlapped were not assessed for micronuclei
count. The micronuclei index was defined as the
number of micronuclei per 3000 hepatocytes. Micro-
nuclei were actually counted in randomly selected
fields and at least 3000 hepatocytes were evaluated,
which represented about 30, 10–20 and 5% of the
areas of cirrhotic nodules, dysplastic nodules, and
hepatocellular carcinomas on the basis of 1 cm sized
lesion, respectively.
Telomere Terminal Restriction Fragment Length
Analysis
Genomic DNA was prepared from 10 to 50 mg of
frozen liver tissue using a standard phenol/chloro-
form extraction after proteinase K treatment. Telo-
mere length was measured by Southern blotting. In
total, 2 mg of DNA digested with 100 U of Hinf I
overnight at 371C was fractionated on a 0.7%
agarose gel. Hybridization was carried out with a
Table 1 Clinical and pathological findings of patients
Case no. Age Sex Etiology Pathological diagnosisa
1 44 F HBV LGDN, HGDN, DN with HCC foci, HCC (2)
2 52 M HBV LGDN, HGDN, DN with HCC foci, HCC (2)
3 50 M HBV LGDN, HCC (2)
4 60 F HBV HGDN, HCC (1)
5 49 M HBV LGDN, HCC (2)
6 59 M HBV LGDN, HGDN, DN with HCC foci
7 48 M HBV LGDN, DN with HCC foci
8 60 M HBV HGDN, DN with HCC foci
9 55 F HBV LGDN, HGDN
10 54 M HBV LGDN, HGDN
11 51 M HBV LGDN
12 48 M HBV LGDN
13 56 M HBV HCC (3)
14 41 M HBV HCC (3)
15 43 M HBV HCC (3)
16 60 M HBV HCC (2)
17 40 M HBV HCC (2)
18 54 F HBV HCC (2)
19 59 M HBV HCC (2)
20 47 M HBV HCC (1)
21 45 M HBV DN with HCC foci
22 60 M HBV HGDN
23 32 F HBV LGDN
24 48 M HBV LGDN
M: male, F: female, HBV: hepatitis B virus, LGDN: low-grade dysplastic nodule, HGDN: high-grade dysplastic nodule, DN with HCC foci:
dysplastic nodule with hepatocellular carcinoma foci, HCC: hepatocellular carcinoma.
a
HCC grading according to the Edmondson and Steiner classification is in parentheses.
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30-end DIG-labeled d(TTAGGG)4 (Roche Molecular
Biochemicals, Mannheim, Germany) at 371C over-
night. After washing the membranes, hybridizations
were detected as recommended by the manufacturer
(Roche Molecular Biochemicals). The mean telo-
mere terminal restriction fragment lengths were
calculated as described earlier.26 Briefly, the result-
ing X-ray film was scanned with a luminescent
image analyzer (Fujifilm, Tokyo, Japan), and the
telomere signal in each lane quantified in a grid
object, defined as a single column with 25 rows,
using the Image Gauge Software 2.54 (Fujifilm).
Figure 1 Histological features of normal liver (a), cirrhosis (b), low-grade dysplastic nodule (c), high-grade dysplastic nodule (d),
dysplastic nodule with hepatocellular carcinoma foci (e), and hepatocellular carcinoma (f) (H&E stain).
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Immunohistochemical Analysis of p21WAF1/CIP1
Paraffin sections were deparaffinized in xylene for
30 min, and then rehydrated with graded alcohol.
Endogenous peroxidase activity was quenched in a
3% hydrogen peroxide/methanol solution for
10 min. For antigen retrieval, sections were boiled
in 100 mM sodium citrate, pH 6.0, for 15 min in a
microwave oven. A monoclonal primary antibody
of p21WAF1/CIP1 (Clone SX118, DAKO, Glostrup,
Denmark) at a 1:50 dilution was applied for 30 min
at room temperature, and then incubated overnight
at 41C. After washing in PBS, incubation with the
secondary antibody was carried out using the
DAKO EnVision Rabbit/Mouse kit for 30 min at
room temperature, after which sections were
developed with diaminobenzidine (DAKO). The
sections were then counterstained with hema-
toxylin, dehydrated using graded alcohol, and
cleared in xylene.
For interpretation of the immunohistochemical
stain results, hepatocytes were counted in at least
five random high-power fields ( 400 magnifica-
tion) so that the number of hepatocytes scored was
at least 500 in every case. Dark brown nuclear
staining of hepatocytes was scored as positive for
p21WAF1/CIP1 and detected in representative fields of
each nodular lesion. Results were expressed as the
p21WAF1/CIP1 labeling index, which is defined as the
percentage of positive hepatocytes.
Statistical Analysis
Statistical analysis was carried out using SPSS
software (SPSS, Inc., Chicago, IL, USA). Mann–
Whitney test was applied to compare telomere
terminal restriction fragment length, micronuclei
index, and p21WAF1/CIP1 labeling index between each
group. Correlation was estimated using Pearson’s
correlation coefficient. Significance was set at
Po0.05 for all tests.
Results
Gradual Increase of Micronuclei Index and Telomere
Shortening during Hepatitis B Virus-Related Multistep
Hepatocarcinogenesis
Micronuclei formation was investigated in each
hepatic nodular lesion and background liver with
cirrhosis (Figure 2). Normal liver samples showed
no micronuclei. The majority of cirrhosis cases (27
cases, 90%) showed no micronuclei and three cases
(10%) showed one micronucleus per 3000 hepato-
cytes. In low-grade dysplastic nodules, there were
12 cases (34%) without micronuclei, 17 (49%) with
one micronucleus, and six (17%) with more than
one micronucleus per 3000 hepatocytes. Micronu-
clei 41 per 3000 hepatocytes were found in 13
(87%) of the high-grade dysplastic nodules and in
all the cases (100%) of dysplastic nodules with
hepatocellular carcinoma foci and hepatocellular
carcinomas. The micronuclei index (number of
micronuclei per 3000 hepatocytes) gradually in-
creased along with the progression of hepatocarci-
nogenesis and it was 0.1±0.06 (mean±s.d.) (range,
0–1) in cirrhosis, 0.9±0.16 (0–4) in low-grade
dysplastic nodules, 3.1±0.38 (0–5) in high-grade
dysplastic nodules, 4.0±0.58 (2–6) in dysplastic
nodules with hepatocellular carcinoma foci, and
12.2±1.93 (4–30) in hepatocellular carcinomas
(Figure 3). A significant increase in the micronuclei
index occurred between cirrhosis and low-grade
dysplastic nodules (Po0.001), as well as between
low-grade dysplastic nodules and high-grade dys-
plastic nodules (Po0.001). Hepatocellular carcino-
mas showed the highest micronuclei index, which
was significantly higher compared with that of high-
grade dysplastic nodules and dysplastic nodules
with hepatocellular carcinoma foci (P¼ 0.002).
Terminal restriction fragment length was mea-
sured by Southern blot analysis and representative
cases are shown in Figure 4. Terminal restriction
fragment length gradually decreased according to
the progression of multistep hepatocarcinogenesis.
Telomere length (kb) was 8.1±0.31 (mean±s.d.)
(range, 7.3–9.3) in normal livers, 7.6±0.29
(4.1–11.3) in cirrhotic livers, 7.2±0.30 (3.6–10.4)
in low-grade dysplastic nodules, 6.6±0.68 (2.9–
11.5) in high-grade dysplastic nodules, 6.2±0.68
(3.6–8.7) in dysplastic nodules with hepatocellular
carcinoma foci, and 6.6±0.57 (3.4–12.0) in hepato-
cellular carcinomas (part of the telomere data was
from an earlier study).12 A significant reduction in
telomere length was found in high-grade dysplastic
nodules and dysplastic nodules with hepatocellular
carcinoma (P¼ 0.024) and hepatocellular carcino-
mas (P¼ 0.031) compared with normal and cirrhotic
livers (Figure 5). However, differences between
cirrhotic livers and low-grade dysplastic nodules,
low-grade dysplastic nodules and high-grade dys-
plastic nodules, high-grade dysplastic nodules and
dysplastic nodules with hepatocellular carcinoma
foci, and dysplastic nodules with hepatocellular
carcinoma foci and hepatocellular carcinomas failed
to reach statistical significance.
The micronuclei index showed a significant
correlation with telomere shortening (r¼0.227,
P¼ 0.016); hepatic nodules with a higher micro-
nuclei index showed shorter telomere length
(Figure 6a). Among 35 low-grade dysplastic nodules,
23 cases (66%) showed micronuclei formation and
their telomere length was 6.3±1.32 kb (range, 3.6–
9.3), whereas it was 8.9±1.18 kb (range, 6.9–10.4) in
low-grade dysplastic nodules without micronuclei.
Telomeres were significantly shorter in low-grade
dysplastic nodules with micronuclei than in those
without (Po0.001) (Figure 6b). It is interesting that
four cases (11%) of low-grade dysplastic nodules
and five cases (33%) of high-grade dysplastic
nodules showed short telomere o5 kb and all of
them showed micronuclei formation.
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Expression of p21WAF1/CIP1 during Hepatitis B
Virus-Related Multistep Hepatocarcinogenesis
p21WAF1/CIP1, cell cycle checkpoint function was
analyzed by immunohistochemical staining in each
hepatic nodule and hepatocellular carcinoma
(Figure 7). The p21WAF1/CIP1 labeling index was
9.0±5.42 (mean±s.d.) (range, 3.1–18.6) in normal
livers, 20.0±13.33 (1.6–47.2) in cirrhotic livers,
8.3±6.24 (2.1–33.7) in low-grade dysplastic
Figure 2 Micronuclei during hepatitis B virus-associated multistep hepatocarcinogenesis. Representative photographs of micronuclei
detected in normal liver (a), cirrhosis (b), low-grade dysplastic nodule (c), high-grade dysplastic nodule (d), dysplastic nodule with
hepatocellular carcinoma foci (e), and hepatocellular carcinoma (f). No micronuclei were found in normal liver. Hepatocytes with
micronuclei are marked by a square line and higher power features are presented in the inset of lower right corner (Feulgen-fast green
stain).
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nodules, 9.3±10.74 (0.8–44.7) in high-grade dys-
plastic nodules, 11.9±8.23 (5.7–29.7) in dysplastic
nodules with hepatocellular carcinoma foci, and
11.7±20.38 (0.4–85.4) in hepatocellular carcino-
mas. The p21WAF1/CIP1 labeling index in cirrhotic
livers was significantly higher than that of normal
livers (P¼ 0.024). It was markedly decreased in low-
grade dysplastic nodules, high-grade dysplastic
nodules, and hepatocellular carcinomas compared
with cirrhotic livers (Po0.05) (Figure 8). Differences
between low-grade dysplastic nodules and high-
grade dysplastic nodules, high-grade dysplastic
nodules and hepatocellular carcinomas, and high-
grade dysplastic nodules with hepatocellular carci-
noma foci and hepatocellular carcinomas failed to
reach statistical significance.
Telomere length showed a significant correlation
with p21WAF1/CIP1 labeling index (r¼ 0.378,
Po0.001); hepatic nodules with shorter telomeres
showed lower p21WAF1/CIP1 labeling index (Figure 9).
However, p21WAF1/CIP1 labeling index did not show a
significant correlation with the micronuclei index
(P40.05), nor did it differ significantly between
low-grade dysplastic nodules with or without
micronuclei formation. It is interesting to note
that p21WAF1/CIP1 labeling index was 6.0±2.20
(mean±s.d.) (range, 3.9–9.1) in low-grade dysplastic
nodules with short telomere o5 kb and 2.7±1.42
(0.8–4.4) in high-grade dysplastic nodules with
short telomere o5 kb and their expression of
p21WAF1/CIP1 checkpoint was inactivated.
Discussion
There has been increasing evidence of a multistep
process in human hepatocarcinogenesis. Allelic
alterations have been reported in early stages of
hepatocarcinogensis, however, the detailed molecu-
lar mechanism underlying the preneoplasia-
carcinoma sequence during hepatocarcinogenesis
is poorly understood.27–30
Chromosomal instability is a characteristic of
hepatitis B virus-related hepatocarcinogenesis.11
The telomere, stabilizing the chromosome ends by
end-to-end fusion, is shortened with each cell
division of somatic cells, as it is not replicated
during the S phase of the cell cycle, and loss of the
telomere leads to the formation of chromosomal
instability.7,8 In this study, telomere length showed a
gradual shortening during hepatitis B virus-related
multistep hepatocarcinogenesis, which was consis-
tent with earlier reports.12,13 The micronucleus, an
indicator of chromosomal instability, was reported
to be associated with an increase in chromosomal
Figure 3 Comparison of micronuclei index in normal livers,
cirrhotic livers, low-grade dysplastic nodules (LGDNs), high-
grade dysplastic nodules (HGDNs), dysplastic nodules with
hepatocellular carcinoma foci (DN with HCC), and hepatocellular
carcinomas (HCCs). The patients (number 1–12) who had multi-
ple lesions including hepatocellular carcinoma and dysplastic
nodules are each characterized by different symbols, and the
other patients who had hepatocellular carcinoma without
synchronously developed dysplastic nodules marked by the same
symbol (x). *Statistical significance (Po0.05).
Figure 4 Telomere terminal restriction fragment length during
hepatitis B virus-associated multistep hepatocarcinogenesis.
Southern blot analysis of terminal restriction fragment length in
cirrhosis, low-grade dysplastic nodule (LGDN), high-grade dys-
plastic nodule (HGDN), and dysplastic nodule with hepatocel-
lular carcinoma foci (DNs with HCC).
Chromosomal instability in dysplastic liver nodules
YH Lee et al
1127
Modern Pathology (2009) 22, 1121–1131
alteration in an in vitro and in vivo study.14–18 The
studies revealed that the frequency of micronuclei
gradually increased during human multistep hepa-
tocarcinogenesis. Micronuclei 41 per 3000 hepato-
cytes was found in 17% of low-grade dysplastic
nodules, 87% of high-grade dysplastic nodules, and
100% of dysplastic nodules with hepatocellular
carcinoma foci and hepatocellular carcinomas in
contrast to all normal livers and 90% of cirrhotic
livers showed no micronuclei. The micronuclei
index (number of micronulei per 3000 hepatocytes)
also increased according to the progression of
multistep hepatocarcinogenesis. A significant in-
crease was found between cirrhotic livers and low-
grade dysplastic nodules, low-grade dysplastic
nodules and high-grade dysplastic nodules, and
dysplastic nodules with hepatocellular carcinoma
foci and hepatocellular carcinomas and hepatocel-
lular carcinomas showed the highest levels of
micronuclei. The micronuclei index was negatively
correlated with telomere length; hepatic nodules
with short telomeres had high numbers of micro-
nuclei. Taken together, these results show that
telomere shortening and chromosomal instability
start to occur in low-grade dysplastic nodules and
high-grade dysplastic nodules, an early stage of
hepatocarcinogenesis.
Inactivation of the DNA damage checkpoint has
recently been suggested as a critical feature in
carcinogenesis models.22,23 In this study, p21WAF1/CIP1
expression was significantly higher in cirrhotic
livers than in normal livers, and these data indicate
that preservation of the p21WAF1/CIP1 checkpoint is an
important defense mechanism in cirrhosis, which is
a risk factor for the development of hepatocellular
carcinoma, in which chromosomal instability and
telomere shortening start to occur, although at a very
low level. In contrast, p21WAF1/CIP1 expression sig-
nificantly decreased in both low-grade dysplastic
nodules and high-grade dysplastic nodules com-
pared with cirrhosis, and it was also significantly
depressed in hepatocellular carcinomas compared
with cirrhosis. The p21WAF1/CIP1 labeling index
showed a significant positive correlation with
telomere length (Po0.001), and hepatic nodules
with shorter telomeres had lower p21WAF1/CIP1 label-
ing index. Therefore, cooperation between telomere
shortening, chromosomal instability, and loss of the
Figure 5 Comparison of telomere terminal restriction fragment
(TRF) length (kb) in normal livers, cirrhotic livers, low-grade
dysplastic nodules (LGDNs), high-grade dysplastic nodules
(HGDNs), dysplastic nodules with hepatocellular carcinoma foci
(DNs with HCC), and hepatocellular carcinomas (HCCs). The
patients (number 1–12) who had multiple lesions including
hepatocellular carcinoma and dysplastic nodules are each
characterized by different symbols, and the other patients who
had hepatocellular carcinoma without synchronously developed
dysplastic nodules marked by the same symbol (x). *Statistical
significance (Po0.05).
Figure 6 Relationship between micronuclei and telomere terminal restriction fragment (TRF) length. (a) The number of micronuclei
showing a significant negative correlation with telomere length (r¼0.227, P¼ 0.016). (b) Comparison of terminal restriction fragment
length between low-grade dysplastic nodules (LGDNs) with and without micronuclei. Low-grade dysplastic nodules with micronuclei
have significantly shorter telomeres than those without (Po0.001).
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p21WAF1/CIP1 checkpoint might evoke further progres-
sion during multistep hepatocarcinogenesis.
The natural outcome of low-grade dysplastic
nodules has been controversial, whereas high-grade
dysplastic nodules were shown to be closely
associated with an increased risk of malignant
transformation.4–6 Kobayashi et al6 reported that
cumulative hepatocellular carcinoma development
rates at the first and fifth years were 46.2 and 80.8%
for high-grade dysplastic nodules, 2.6 and 36.6% for
Figure 7 Expression of p21WAF1/CIP1 during hepatitis B virus-associated multistep hepatocarcinogenesis. Representative photographs of
p21WAF1/CIP1 immunostaining in cirrhotic liver (a), low-grade dysplastic nodule (b), high-grade dysplastic nodule (c), dysplastic nodule
with hepatocellular carcinoma foci (d), and hepatocellular carcinoma (e and f). The border of hepatocellular carcinoma is marked by a
dotted line (f). Note that cirrhosis (below the line) shows higher p21WAF1/CIP1 expression compared with hepatocellular carcinoma (above
the line).
Chromosomal instability in dysplastic liver nodules
YH Lee et al
1129
Modern Pathology (2009) 22, 1121–1131
low-grade dysplastic nodules, and 3.3 and 12.4% for
cirrhotic regenerative nodules, respectively. Borzio
et al5 reported that high-grade dysplastic nodules
were strong predictors of malignant transformation;
however, low-grade dysplastic nodules were not at
increased risk for hepatocellular carcinoma. Inter-
estingly, this study found that 11% of low-grade
dysplastic nodules showed short telomere (o5 kb)
and all of them had micronuclei formation. Cells
with critically shortened telomeres gain further
chromosomal instability through breakage-fusion-
bridge cycles during replication, which has a
catastrophic effect on cells. However, telomerase
reactivation can stabilize the chromosome ends and
produce aberrant yet stable chromosomes; these
cells then gain immortality.31 We earlier reported
that the reactivation of telomerase occurred in
dysplastic nodules, an early stage of hepatocarcino-
genesis, and moreover, 7% of low-grade dysplastic
nodules showed telomerase activation in our earlier
study, although the majority of low-grade dysplastic
nodules were telomerase negative.12,32 In this study,
expression of the p21WAF1/CIP1 checkpoint was
significantly depressed in low-grade dysplastic
nodules compared with cirrhosis, and all of the
low-grade dysplastic nodules with short telomere
(o5 kb) showed inactivation of p21WAF1/CIP1 check-
point. Taken together, it suggests that low-grade
dysplastic nodules might be a biologically hetero-
geneous group, although histological differences
are very hard to detect. A small fraction, about
11% of low-grade dysplastic nodules with telomere
shortening, micronuclei, and inactivation of the
p21WAF1/CIP1 checkpoint, might have the potential
to progress to further, more advanced lesions in
human hepatocarcinogenesis.
In conclusion, chromosomal instability, telomere
shortening, and inactivation of the p21WAF1/CIP1
checkpoint occur in both low-grade dysplastic
nodules and high-grade dysplastic nodules, which
are preneoplastic lesions of human multistep hepa-
tocarcinogenesis. Their co-occurrence is suggested
to be critical for malignant transformation during
hepatitis B virus-associated human multistep hepa-
tocarcinogenesis.
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